Cargando…

Serological and molecular prevalence of selected canine vector borne pathogens in blood donor candidates, clinically healthy volunteers, and stray dogs in North Carolina

BACKGROUND: Canine vector borne diseases (CVBDs) comprise illnesses caused by a spectrum of pathogens that are transmitted by arthropod vectors. Some dogs have persistent infections without apparent clinical, hematological or biochemical abnormalities, whereas other dogs develop acute illnesses, per...

Descripción completa

Detalles Bibliográficos
Autores principales: Balakrishnan, Nandhakumar, Musulin, Sarah, Varanat, Mrudula, Bradley, Julie M, Breitschwerdt, Edward B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972993/
https://www.ncbi.nlm.nih.gov/pubmed/24655461
http://dx.doi.org/10.1186/1756-3305-7-116
_version_ 1782309653801074688
author Balakrishnan, Nandhakumar
Musulin, Sarah
Varanat, Mrudula
Bradley, Julie M
Breitschwerdt, Edward B
author_facet Balakrishnan, Nandhakumar
Musulin, Sarah
Varanat, Mrudula
Bradley, Julie M
Breitschwerdt, Edward B
author_sort Balakrishnan, Nandhakumar
collection PubMed
description BACKGROUND: Canine vector borne diseases (CVBDs) comprise illnesses caused by a spectrum of pathogens that are transmitted by arthropod vectors. Some dogs have persistent infections without apparent clinical, hematological or biochemical abnormalities, whereas other dogs develop acute illnesses, persistent subclinical infections, or chronic debilitating diseases. The primary objective of this study was to screen healthy dogs for serological and molecular evidence of regionally important CVBDs. METHODS: Clinically healthy dogs (n = 118), comprising three different groups: Gp I blood donor candidates (n = 47), Gp II healthy dog volunteers (n = 50), and Gp III stray dogs (n = 21) were included in the study. Serum and ethylenediamine tetraacetic acid (EDTA) anti-coagulated blood specimens collected from each dog were tested for CVBD pathogens. RESULTS: Of the 118 dogs tested, 97 (82%) dogs had been exposed to or were infected with one or more CVBD pathogens. By IFA testing, 9% of Gp I, 42% of Gp II and 19% of Gp III dogs were seroreactive to one or more CVBD pathogens. Using the SNAP 4DX® assay, Gp I dogs were seronegative for Anaplasma spp., Ehrlichia spp., and B. burgdorferi (Lyme disease) antibodies and D. immitis antigen. In Gp II, 8 dogs were Ehrlichia spp. seroreactive, 2 were infected with D. immitis and 1 was B. burgdorferi (Lyme disease) seroreactive. In Gp III, 6 dogs were infected with D. immitis and 4 were Ehrlichia spp. seroreactive. Using the BAPGM diagnostic platform, Bartonella DNA was PCR amplified and sequenced from 19% of Gp I, 20% of Gp II and 10% of Gp III dogs. Using PCR and DNA sequencing, 6% of Gps I and II and 19% of Gp III dogs were infected with other CVBD pathogens. CONCLUSION: The development and validation of specific diagnostic testing modalities has facilitated more accurate detection of CVBDs. Once identified, exposure to vectors should be limited and flea and tick prevention enforced.
format Online
Article
Text
id pubmed-3972993
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39729932014-04-03 Serological and molecular prevalence of selected canine vector borne pathogens in blood donor candidates, clinically healthy volunteers, and stray dogs in North Carolina Balakrishnan, Nandhakumar Musulin, Sarah Varanat, Mrudula Bradley, Julie M Breitschwerdt, Edward B Parasit Vectors Research BACKGROUND: Canine vector borne diseases (CVBDs) comprise illnesses caused by a spectrum of pathogens that are transmitted by arthropod vectors. Some dogs have persistent infections without apparent clinical, hematological or biochemical abnormalities, whereas other dogs develop acute illnesses, persistent subclinical infections, or chronic debilitating diseases. The primary objective of this study was to screen healthy dogs for serological and molecular evidence of regionally important CVBDs. METHODS: Clinically healthy dogs (n = 118), comprising three different groups: Gp I blood donor candidates (n = 47), Gp II healthy dog volunteers (n = 50), and Gp III stray dogs (n = 21) were included in the study. Serum and ethylenediamine tetraacetic acid (EDTA) anti-coagulated blood specimens collected from each dog were tested for CVBD pathogens. RESULTS: Of the 118 dogs tested, 97 (82%) dogs had been exposed to or were infected with one or more CVBD pathogens. By IFA testing, 9% of Gp I, 42% of Gp II and 19% of Gp III dogs were seroreactive to one or more CVBD pathogens. Using the SNAP 4DX® assay, Gp I dogs were seronegative for Anaplasma spp., Ehrlichia spp., and B. burgdorferi (Lyme disease) antibodies and D. immitis antigen. In Gp II, 8 dogs were Ehrlichia spp. seroreactive, 2 were infected with D. immitis and 1 was B. burgdorferi (Lyme disease) seroreactive. In Gp III, 6 dogs were infected with D. immitis and 4 were Ehrlichia spp. seroreactive. Using the BAPGM diagnostic platform, Bartonella DNA was PCR amplified and sequenced from 19% of Gp I, 20% of Gp II and 10% of Gp III dogs. Using PCR and DNA sequencing, 6% of Gps I and II and 19% of Gp III dogs were infected with other CVBD pathogens. CONCLUSION: The development and validation of specific diagnostic testing modalities has facilitated more accurate detection of CVBDs. Once identified, exposure to vectors should be limited and flea and tick prevention enforced. BioMed Central 2014-03-24 /pmc/articles/PMC3972993/ /pubmed/24655461 http://dx.doi.org/10.1186/1756-3305-7-116 Text en Copyright © 2014 Balakrishnan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Balakrishnan, Nandhakumar
Musulin, Sarah
Varanat, Mrudula
Bradley, Julie M
Breitschwerdt, Edward B
Serological and molecular prevalence of selected canine vector borne pathogens in blood donor candidates, clinically healthy volunteers, and stray dogs in North Carolina
title Serological and molecular prevalence of selected canine vector borne pathogens in blood donor candidates, clinically healthy volunteers, and stray dogs in North Carolina
title_full Serological and molecular prevalence of selected canine vector borne pathogens in blood donor candidates, clinically healthy volunteers, and stray dogs in North Carolina
title_fullStr Serological and molecular prevalence of selected canine vector borne pathogens in blood donor candidates, clinically healthy volunteers, and stray dogs in North Carolina
title_full_unstemmed Serological and molecular prevalence of selected canine vector borne pathogens in blood donor candidates, clinically healthy volunteers, and stray dogs in North Carolina
title_short Serological and molecular prevalence of selected canine vector borne pathogens in blood donor candidates, clinically healthy volunteers, and stray dogs in North Carolina
title_sort serological and molecular prevalence of selected canine vector borne pathogens in blood donor candidates, clinically healthy volunteers, and stray dogs in north carolina
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972993/
https://www.ncbi.nlm.nih.gov/pubmed/24655461
http://dx.doi.org/10.1186/1756-3305-7-116
work_keys_str_mv AT balakrishnannandhakumar serologicalandmolecularprevalenceofselectedcaninevectorbornepathogensinblooddonorcandidatesclinicallyhealthyvolunteersandstraydogsinnorthcarolina
AT musulinsarah serologicalandmolecularprevalenceofselectedcaninevectorbornepathogensinblooddonorcandidatesclinicallyhealthyvolunteersandstraydogsinnorthcarolina
AT varanatmrudula serologicalandmolecularprevalenceofselectedcaninevectorbornepathogensinblooddonorcandidatesclinicallyhealthyvolunteersandstraydogsinnorthcarolina
AT bradleyjuliem serologicalandmolecularprevalenceofselectedcaninevectorbornepathogensinblooddonorcandidatesclinicallyhealthyvolunteersandstraydogsinnorthcarolina
AT breitschwerdtedwardb serologicalandmolecularprevalenceofselectedcaninevectorbornepathogensinblooddonorcandidatesclinicallyhealthyvolunteersandstraydogsinnorthcarolina